Tech Company Financing Transactions

SiteOne Therapeutics Funding Round

Amgen Ventures, Biobrit and Mission Bay Capital participated in a $15 million Series B venture round for SiteOne Therapeutics. The round closed on 1/11/2017.

Transaction Overview

Company Name
SiteOne Therapeutics
Announced On
1/11/2017
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series B
Investors

Amgen Ventures (Lead Investor) (David Reese)

Biobrit

Mission Bay Capital (Doug Crawford)

Next Frontier Capital (Will Price)

Sears Capital Management (Lowell Sears)

Z Investments

Proceeds Purpose
This Series B financing and collaboration with Amgen will allow us to accelerate the development of our Na?1.7 therapeutic candidates in multiple potential applications for managing acute and chronic pain without the addiction potential and other significant side-effects of existing therapies.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
203 Enterprise Blvd. 3
Bozeman, MT 59718
USA
Phone
(406) 461-4618
Website
www.site1therapeutics.com
Email Address
[email protected]
Overview
SiteOne Therapeutics, located in San Francisco, is developing novel therapeutics and diagnostics to safely, effectively and efficiently treat acute and chronic pain without the limitations of existing therapies, such as NSAIDs and opioids.
Profile
SiteOne Therapeutics LinkedIn Company Profile
Social Media
SiteOne Therapeutics Company Twitter Account
Company News
SiteOne Therapeutics News
Facebook
SiteOne Therapeutics on Facebook
YouTube
SiteOne Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Stan Abel
  Stan Abel LinkedIn Profile  Stan Abel Twitter Account  Stan Abel News  Stan Abel on Facebook
Controller
Anne Martin
  Anne Martin LinkedIn Profile  Anne Martin Twitter Account  Anne Martin News  Anne Martin on Facebook
VP - Bus. Development
Debra Odink
  Debra Odink LinkedIn Profile  Debra Odink Twitter Account  Debra Odink News  Debra Odink on Facebook
VP - R & D
John Mulcahy
  John Mulcahy LinkedIn Profile  John Mulcahy Twitter Account  John Mulcahy News  John Mulcahy on Facebook

 

 

Browse more venture capital transactions:

Prev: 1/11/2017: KWIPPED venture capital transaction
Next: 1/11/2017: Logtrust venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to document all VC transactions involving tech companies. VC investment data records on this site are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.